Surfactant aerosol - Chiesi
Latest Information Update: 14 Jan 2016
At a glance
- Originator Chiesi
- Class Surfactants
- Mechanism of Action Cell membrane permeability enhancers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Clinical Phase Unknown Neonatal respiratory distress syndrome
Most Recent Events
- 14 Jan 2016 Clinical trials in Neonatal respiratory distress syndrome in Italy (Inhalation) prior to January 2016 (Chiesi pipeline, January 2016)